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An analytical strategy is described for analyzing quaternary ammonium neuromuscular
blocking agents in a wide variety of biological specimens in a forensic setting. Neuromuscular
blocking agents such as succinylcholine, pancuronium, and tubocurarine, often used as
paralytic agents during surgery, are occasionally suspected as paralytic poisoning agents
involved in suspected homicide and suicide cases. Because suspicion in such cases can develop
slowly, the age, nature, and quality of available specimens varies greatly. The compounds are
challenging analytically because of their simultaneous precharged yet lipophilic character. An
analytical strategy has been devised for extracting these compounds from complex matrices
using a combination of a modified Bligh and Dyer liquid-liquid extraction (used in reverse)
followed by reverse-phase ion pairing solid-phase extraction using heptafluorobutyric acid as
an ion pairing reagent. Final analysis is by LC-MS/MS using a tandem quadrupole orthogonal
acceleration time of flight instrument (Q-TOF) with repetitive product ion scanning at high
resolution. Native and spiked specimens are compared for both quantitative and especially
qualitative purposes. The method has been applied to a wide variety of fluid and tissue
specimen types, including numerous specimens from exhumation autopsies. For most
specimens, detection limits are in the 2 to 10 ng/g range. Succinylmonocholine has been
demonstrated to be present at low levels in normal posthumous kidney and liver. The Q-TOF
is an excellent platform for forensic analytical investigations. This analytical strategy should
also be applicable to other problematic analytes and sample matrices. (J Am Soc Mass
Spectrom 2006, 17, 1456–1468) © 2006 American Society for Mass SpectrometryQuaternary ammonium neuromuscular blockingagents are paralytic drugs used primarily by
anesthesiologists to paralyze patients during
surgical procedures. They are also used as paralytic
agents in veterinary and laboratory animal medicine.
Drugs in this category include well-known compounds
such as succinylcholine, tubocurarine (curare), and pan-
curonium. Pharmacologically, these drugs block the
effects of the neurotransmitter acetylcholine in skeletal
muscle, resulting in the paralysis of all voluntary mus-
cles and the diaphragm, the principal muscle of breath-
ing. Thus, a patient exposed to a clinically effective dose
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own, and some form of artificial ventilation must be
provided whenever these drugs are used, typically in
the form of a mechanical respirator. The dose relation-
ships and duration of action of these drugs are well
known and generally quite predictable, and there is
little clinical need to measure blood or urine levels of
these drugs, except in possible accidental overdose
situations or instances of unexpected, prolonged
paralysis.
In terms of toxicity and forensics, a clinically effec-
tive dose of one of these drugs can also be a lethal dose
if respiratory assistance is not provided. Thus, neuro-
muscular blocking agents are potential murder weap-
ons. They may be particularly attractive to a potential
poisoner because they are not routinely measured and,
indeed, few forensic laboratories will even attempt to
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there is little need to measure them clinically and, thus,
no routine assays are available, and partially because
they are analytically challenging compounds. Never-
theless, the potential for their use as murder weapons
must be considered, particularly in cases involving
sudden, unexpected, and unexplained death with a
medical professional as a potential suspect, both within
and outside of a hospital setting. Succinylcholine in
particular has a long reputation as an undetectable,
“perfect” poison.
The analysis of quaternary ammonium neuromuscu-
lar blocking agents in a forensic setting is challenging
for two reasons. The first reason is that the chemical
behavior of these compounds, involving both hydro-
philic and lipophilic characteristics, makes them diffi-
cult to isolate from biological specimens. The second
reason is the extraordinary variability of the types of
specimens encountered; this variability is such that each
specimen must be considered unique. This laboratory
now has approximately six years of experience with
these analyses, involving more than 450 tissue and fluid
specimens, very few of which could be considered to be
alike. Specimens have included some relatively fresh
clinical liquid samples such as blood, plasma, and
urine, but the vast majority of the specimens have been
tissues. Some of these specimens were from autopsies
conducted immediately after the death. Some of these
had been refrigerated, some were frozen, some were
formalin-fixed, and some were embedded in paraffin
blocks. Some were from a decedent who had been
embalmed before autopsy but not yet buried, with the
specimens then frozen for several years. Some were
from decedents who were embalmed, buried for one to
ten years, then exhumed and autopsied. Some of the
latter autopsy specimens were then stored frozen for
several years before analysis. With this variability in the
history and condition of the specimens, no two liver
samples and no two kidney samples could be consid-
ered alike (even from the same decedent).
Because each of these specimens is unique and
cannot legitimately be duplicated, it is not possible to
“validate” the analytical methods for these samples in
the usual sense of that term, which involves large
numbers of identical known specimens and statistical
analyses for precision and accuracy. The approach of
this laboratory was to develop a method that was
intended to be broadly applicable to a wide variety of
specimens, to ensure that the method works very well
for pristine samples such as spiked serum standards
and spiked tissue homogenates, and then to apply the
method to unique specimens in such a way that each
specimen serves as its own control, both qualitatively
and quantitatively, using the well-known method of
standard additions [1, 2]. The analytical methods de-
scribed here are currently being applied in this labora-
tory to the following neuromuscular blocking agents
and/or their breakdown products: succinylcholine, suc-
cinylmonocholine, pancuronium, vecuronium, tubocu-rarine, rocuronium, atracurium, mivacurium, and doxa-
curium. Since it is structurally similar and a potential
poison, the quaternary cardiotonic drug bretylium is
also included in this assay. Structures of the quaternary
parent drugs involved in these studies are shown in
Table 1, with additional structures of potentially signif-
icant breakdown products of some of the drugs shown
in Table 2.
Initial studies indicated that several of these ana-
lytes, particularly the larger compounds such as pancu-
ronium, bind extensively to the membranous compo-
nents of tissues. Aqueous and standard liquid–liquid
extraction approaches were inefficient for extracting
these compounds. This observation was consistent with
the simultaneous water-soluble yet highly lipophilic
character of these compounds. An analytical strategy
was devised to take advantage of the power of the Bligh
and Dyer mixture for disrupting cell membranes [3].
The Bligh and Dyer mixture is a monophasic blend of
water, methanol, and chloroform. The classic Bligh and
Dyer procedure was originally intended for isolating
lipids from plasma membranes in tissue specimens.
Here, it is used in reverse (in slightly modified form),
with the final aqueous component, rather than the
organic component, taken as an initial extract. The
second stage of extraction is a reverse phase ion pairing
solid-phase extraction procedure using C18 extraction
cartridges, with heptafluorobutyric acid used as an ion
pairing reagent. This approach is derived from ion
pairing principles originally intended for isolating pep-
tides, but which are also applicable to quaternary
Succinylcholine 
  
Bretylium Tubocurarine
Pancuronium Vecuronium
Rocuronium Atracurium
Mivacurium Doxacurium
Table 1. Structures of the parent drugsammonium compounds and to basic compounds in
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using [2H4]succinylmonocholine as an internal stan-
dard. The overall method thus involves two stages of
extraction based upon fundamentally different princi-
ples, with LC-MS/MS under ion pairing conditions as
the analytical finish. This overall analytical strategy has
proven to be very efficient for these challenging ana-
lytes in disparate sample types, and it may well be
applicable to other challenging analytes with similar
problematic characteristics, or for compounds that are
highly compartmentalized in the intracellular space.
Since the most important question being addressed
through these analyses usually concerns the qualitative
presence or absence of these xenobiotics (with quanti-
tative estimation usually of secondary importance), a
major focus of this project was to incorporate into the
analyses the qualitative power of the modern quadru-
pole/time-of-flight (Q-TOF) tandem mass spectrome-
ter. Most liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) analyses conducted in forensic
laboratories involve monitoring only for two or three
product ions characteristic of an analyte, using a tan-
dem quadrupole instrument. The Q-TOF, however,
which provides full scan product ion spectra at high
resolution, has the potential to answer the qualitative
question with a very high level of analytical confidence,
and one of the goals of this project was to evaluate that
potential in a forensic setting.
Several previous methods have been described for
analyzing various neuromuscular blocking agents (and
quaternary compounds in general) by mass spectromet-
 
Succinylmonocholine 
  
Atracurium Quaternary Acid Atracurium Quaternary Alcohol 
  
Atracurium Quat. Monoacrylate Laudanosine 
  
Doxacurium Quaternary Alcohol Doxacurium Quaternary Acid 
 
Mivacurium Quaternary Alcohol Mivacurium Quaternary Acid 
Table 2. Structures of potentially significant breakdown prod-
ucts derived from the parent drugsric means [5–29]. In addition to incorporating the Q-TOF, the analytical strategy described here is intended
to provide high overall efficiency for numerous chal-
lenging analytes with a wide range of specimen types,
particularly tissues in widely varying stages of
preservation.
Experimental
Materials
Succinylcholine, succinylmonocholine, pancuronium,
and tubocurarine were obtained from U.S. Pharmaco-
peia (Rockville, MD). Vecuronium and rocuronium
were obtained as injectable solutions from Organon
(West Orange, NJ). Atracurium, mivacurium, and doxa-
curium were obtained as injectable solutions from Gl-
axoWellcome (Research Triangle Park, NC). The sol-
vents methanol, chloroform, and hexane were of
Optima grade from Fisher (Pittsburg, PA). Heptafluoro-
butyric acid (HFBA) and choline chloride were from
Sigma (St. Louis, MO). Solid-phase extraction columns
were Varian (Harbor City, CA) Bond Elut-C18 columns
with 500 mg of bed material and a 3 ml capacity.
[2H9]Choline chloride (99.5 atom%
2H) was obtained
from C/D/N Isotopes (Quebec, Canada). [2H8]Succinyl-
choline (98 atom% 2H) was obtained as a custom
synthesis from Medical Isotopes (Pelham, NH).
[2H4]Succinylmonocholine was generated in-house
from the [2H8]succinylcholine through hydrolysis at
room temperature under mildly basic conditions (am-
monium hydroxide, Fisher), with the hydrolysis
stopped after full consumption of the starting material
through acidification with formic acid (Fisher). Dilu-
tions of the resulting solution were then compared by
LC-MS/MS to unlabeled material to estimate the con-
centration of the [2H4]succinylmonocholine. A similar
hydrolysis procedure under mildly basic conditions
was used to generate the breakdown products of atra-
curium and mivacurium, which were then preserved
through acidification. The breakdown products of
doxacurium were present as low-level contaminants in
the doxacurium injectable liquid and were not deliber-
ately generated.
Sample Preparation
Liquid specimens were aliquotted directly (typically 0.1
ml) into 16  125 mm glass tubes with Teflon-lined
screw caps. Weighed tissue specimens were homoge-
nized with aqueous 0.088% formic acid to yield homog-
enates of known dilution factor, typically 1/4 or 1/10,
with 0.25 to 0.5 ml aliquots taken. Paraoxon (100 ng/l
in methanol, 1 l) was added to each sample to inhibit
esterase activity. Internal standard ([2H4]succinyl-
monocholine, 1 ng/l, 25 l) was added and, for spiked
samples, a small-volume (typically 2–20 l) of a spiking
solution containing all the analytes (except succinylcho-
line) at known concentration (1 ng/l or 10 ng/l) was
added. After the samples were vortexed, sufficient
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men to bring its total volume to 1.0 ml, and the samples
were vortexed again. Using repipettor bottles (Kendall,
Mansfield, MA), 2.5 ml of methanol and 1.25 ml of
chloroform were added to form the monophasic Bligh
and Dyer mixture. The specimens were then capped
and placed on an automatic rotator for 30 min. Follow-
ing the addition via repipettor of 1.5 ml hexane and 0.75
ml chloroform to render the system biphasic, the
capped samples were returned to the automatic rotator
for 5 min. The specimens were then centrifuged on a
tabletop centrifuge at 3000 rpm for 5 min, following
which the upper (aqueous) layer was transferred using
plastic disposable pipettes to 10 ml conical screw-
capped glass tubes. The initial extracts were then evap-
orated to dryness under a stream of nitrogen at 55 °C on
a TurboVap (Zymark, Hopkinton, MA); this step typi-
cally required 90 min and, if necessary, samples were
stored in this dry condition overnight at 4 °C.
The samples were reconstituted with 2 ml of aqueous
0.1% HFBA, sonicated for 5 min, and vortexed. The
following ion pairing solid-phase extraction procedure
was performed either manually using a vacuum or
positive pressure manifold set-up or robotically using
RapidTrace devices (Zymark). The C18 extraction col-
umns were conditioned twice with 2.5 ml of 0.1%
HFBA/methanol, then equilibrated twice with 2.5 ml of
aqueous 0.1% HFBA. The samples were then loaded
and the columns were rinsed twice with 1 ml of
aqueous 0.1% HFBA, followed by a rinse with 0.75 ml of
0.1% HFBA/15% methanol/water. The samples were
eluted into 12  75 mm glass tubes using two succes-
sive passes with 1 ml of 0.1% HFBA/80% methanol/
water, followed by two successive passes with 1 ml of
0.1% HFBA/90% methanol/water. The combined elu-
ates were then evaporated to dryness under a stream of
nitrogen at 55 °C on a TurboVap (30–45 min). The dry
samples were reconstituted with brief sonication and
vortexing in 0.2 ml of aqueous 0.1% HFBA, and centri-
fuged for 5 min at 3000 rpm. The supernatants were
transferred to plastic autosampler vials with conical
interiors; the vials were capped with Teflon-lined caps,
and 15 l aliquots were analyzed by LC-MS/MS.
Liquid Chromatography-Tandem
Mass Spectrometry
The liquid chromatographic system consisted of two
Shimadzu (Tokyo, Japan) LC-10ADVP pumps, a Shi-
madzu Sil-HTC autosampler, a Shimadzu FCV-10ALVP
flow controller, two Shimadzu DGU-14A solvent degas-
sers, and a Shimadzu CTO-10ASVP column oven. The
column was a Thermo (Bellefonte, PA) Hypersil-
Keystone BetaBasic-18 100  2.1 mm C18 column
packed with 3 m particles with 150 Å pores. The
column temperature was maintained at 37 °C. The
ion-pairing solvent system consisted of Solvent A,
which was aqueous 0.1% HFBA, and Solvent B, whichwas 0.1% HFBA/methanol. The initial mobile phase
was 5% Solvent B at a flow rate of 0.1 ml/min. After
injection, the initial mobile phase conditions were main-
tained for 6 min, at which time a linear gradient was
initiated, achieving 95% Solvent B at 20 min. At 26 min,
the solvent composition was switched back to 5%
Solvent B and the flow rate increased to 0.2 ml/min to
re-equilibrate the column with the initial mobile phase.
The flow rate was restored to 0.1 ml/min at 35.1 min,
with total run time of 35.2 min.
The effluent from the LC system was directly intro-
duced (with no flow splitting) into the electrospray ion
source of a Q-TOF tandem mass spectrometer (Micro-
mass, Manchester, UK). The Q-TOF was a Q-TOF I
upgraded with a 4 GHz time-to-digital converter. Ni-
trogen was used as the nebulizing and desolvation gas,
with the source operated at 120 °C and the desolvation
gas at 425 °C. The capillary was operated at 3500 V.
Argon was used as the collision gas, with the collision
gas pressure optimized to maximize the overall yield of
product ions from the analytes of interest (16 psi
indicated head pressure with the standard controlled
leak into the collision cell). Cone voltages and labora-
tory frame-of-reference collision energies used for each
of the analytes are delineated in Table 3. MS1 was
operated at relatively low resolution (low mass and
high mass settings of 5–10, representing an m/zwindow
of 3–5) to maximize the transmission of the precursors
and thus enhance overall sensitivity. MS2 was operated
at a resolution of 5000 to 7000, representing a good
overall balance between sensitivity and resolution with
this instrument configuration.
Organization of a Typical Analytical Run
The analysis of biological specimens typically involved
quadruplicate aliquots, two of which were treated as
native specimens and two of which were spiked at two
different levels with known amounts of a mixture of all
of the analytes except succinylcholine, (which was
excluded for initial analyses since it is seldom detected
and since its breakdown to succinylmonocholine would
distort the quantification of that analyte). As an alter-
native, one of the native aliquots often represented a
standard dilution (by a factor of two) of the other native
specimen, with the latter identical in volume and dilu-
tion factor to the spiked specimens. Control specimens
included a reagent blank, blank human serum, blank
human serum without internal standard, and several
low-level standards prepared in blank serum. Analyti-
cal specimens involving positive findings were typi-
cally subjected to repeat analysis with the instrument
monitoring only the analytes of interest, and with
spiking levels and/or dilution factors adjusted as nec-
essary to facilitate quantification. On the rare occasions
when succinylcholine itself was detected during initial
analysis, the specimens were re-analyzed using
[2H8]succinylcholine as the internal standard, with ad-
ditional specimens and standards spiked with appro-
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Analyte Parent m/z
Retention
time (min)
Cone
voltage (V)
Collision
energy (eV)
Significant product ions [m/z (relative
abundance)]
Succinylmonocholine 204 14.25 24 23 99 (53%), 101 (24%), 145 (100%)
[2H4]Succinylmonocholine 208 14.2 24 23 103 (63%), 101 (17%), 149 (100%)
Succinylcholine 145 (2) 18.9 22 12 79.5 (2, 8%), 93.5 (2, 33%), 115.6 (2,
100%), 145,1 (M2, 25%), 171 (6%), 230
(3%)
Choline 104 11.9 35 16 45 (1%), 60 (2%), 104 (M, 100%)
[2H9]Choline 113 11.72 35 16 45 (1%), 69 (2%), 113 (M
, 100%)
Pancuronium 286 (2) 21.2 25 16 100 (27%), 206.6 (2, 75%), 236.6 (2, 26%),
286 (M2, 23%), 332 (13%), 430 (100%), 472
(34%)
Des-acetyl pancuronium 265 (2) 20.9 25 16 100 (24%), 206.6 (2, 5%), 265 (M2, 100%),
388 (7%), 430 (28%)
Des-diacetyl pancuronium 244(2) 20.9 25 16 100 (17%), 185.6 (2, 5%), 244 (M2, 100%),
388 (22%)
Vecuronium 557 21.4 45 35 100 (66%), 338 (53%), 356 (68%), 398 (32%),
416 (16%), 497 (14%), 557 (M, 100%)
Des-acetyl vecuronium 515 21.2 45 35 100 (68%), 338 (28%), 356 (70%), 374 (52%),
398 (13%), 416 (16%), 515 (M, 100%)
Des-diacetyl vecuronium 473 21.25 45 35 100 (62%), 356 (42%), 374 (39%) 473 (M,
100%)
Tubocurarine 609 20.4 50 38 174 (46%), 192 (22%), 267 (16%), 284 (37%),
297 (83%), 310 (22%), 386 (100%), 398
(14%), 458 (13%), 521 (29%), 533 (28%), 548
(15%), 564 (96%), 609 (M, 74%)
Rocuronium 529 21.0 35 32 112 (29%), 340 (13%), 358 (21%), 376 (13%),
413 (17%), 487 (100%), 529 (M, 84%)
Des-acetyl rocuronium 487 21.05 35 32 112 (33%), 358 (23%), 376 (13%), 445 (84%),
487 (M, 100%)
Atracurium 464 (2) 21.7 35 21 151 (42%), 157 (22%), 165 (27%), 174 (12%),
189 (100%), 204 (11%), 244 (33%), 296
(14%), 307 (91%), 314 (11%), 327 (60%), 358
(27%), 370 (20%), 412 (16%), 464 (M2,
58%), 516 (13%), 601 (43%), 763 (5%)
Mivacurium 514 (2) 21.9 32 24 181 (14%), 189 (65%), 256 (13%), 258 (16%),
320 (33%), 342 (100%), 357 (46%), 428
(31%), 514 (M2, 57%), 600 (25%), 626
(8%), 669 (12%), 671 (43%), 833 (3%)
Doxacurium 517 (2) 22.6 35 25 181 (39%), 188 (20%), 195 (91%), 204 (18%),
219 (100%), 330 (48%), 356 (18%), 387
(37%), 426 (16%), 458 (26%), 517 (M2,
44%), 576 (21%), 647 (51%), 839 (8%)
Laudanosine 358 [MH] 20.6 35 23 151 (26%), 165 (10%), 189 (38%), 206 (100%),
327 (15%), 358 ([MH], 13%)
Atracurium quaternary
acid
430 20.1 35 23 116 (89%), 151 (41%), 165 (23%), 174 (14%),
189 (91%), 296 (16%), 327 (55%), 370 (34%),
430 (M, 100%)
Atracurium quaternary
alcohol
516 20.7 35 25 151 (10%), 165 (6%), 189 (15%), 202 (100%),
327 (12%), 370 (42%), 412 (6%), 430 (4%),
516 (M, 51%)
Atracurium quaternary
monoacrylate
570 22.0 35 30 151 (9%), 165 (7%), 189 (18%), 256 (100%),
327 (12%), 370 (16%), 570 (M, 17%)
Mivacurium quaternary
Acid
600 21.2 35 28 189 (14%), 213 (28%), 256 (100%), 357 (8%),
428 (10%), 600 (M, 50%)
Mivacurium Quaternary
alcohol
446 20.2 35 25 102 (100%), 165 (11%), 181 (21%), 189 (68%),
195 (15%), 357 (22%), 359 (18%), 402 (19%),
446 (M, 89%)
Doxacurium quaternary
alcohol
476 21.3 45 30 102 (52%), 181 (97%), 188 (63%), 195 (67%),
204 (33%), 219 (100%), 235 (16%), 250
(25%), 266 (17%), 281 (17%), 294 (17%), 341
(14%), 356 (33%), 389 (14%), 401 (11%), 432
(14%), 476 (M, 25%)
Doxacurium quaternary
acid
576 21.2 45 32 159 (38%), 181 (25%), 188 (16%), 195 (36%),
202 (100%), 219 (64%), 356 (17%), 387
(15%), 458 (17%), 576 (M, 55%)Bretylium 242 20.0 32 34 90 (15%), 169 (100%)
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samples were re-analyzed for choline using [2H9]choline
as an internal standard. Quantitative estimation of posi-
tive findings was based upon a straightforward calcula-
tion using the method of standard additions, generally
taking into account the response of the internal standard.
Results and Discussion
All of these compounds (except laudanosine) are pre-
charged, with pancuronium, atracurium, mivacurium,
and doxacurium doubly charged. The fixed positive
charges on these compounds necessarily imparts hy-
drophilicity to that portion of the molecule, but most of
these compounds also have substantial portions that are
nonpolar in character. This nonpolar character probably
explains observations during initial studies, which sug-
gested substantial binding of drugs such as pancuro-
nium to membranous constituents of tissues, to an
extent that aqueous based and standard liquid-liquid
extractions resulted in poor recoveries. The Bligh and
Dyer mixture, which is a monophasic blend of water,
methanol, and chloroform, was originally used to dis-
rupt cellular membranes for the purpose of isolating
membrane lipids. The modified variant of the Bligh and
Dyer procedure described here uses hexane and chlo-
roform instead of water and chloroform to render the
system biphasic. The hexane was incorporated to re-
duce the polarity of the organic phase and drive the
analytes into the aqueous phase.
The precharged character of these quaternary com-
pounds (and the basic character of laudanosine) facili-
tates the formation of lipophilic ion pairs between these
compounds and perfluorinated alkanoic acids such as
trifluoroacetic acid and heptafluorobutyric acid. In gen-
eral, the degree to which such ion pairs adhere to
reverse phase materials such as C18 increases as the
length of the chain of the perfluorinated acid increases
[4]. This is consistent with the observations during these
studies. The use of heptafluorobutyric acid provided
better overall performance, both for the solid-phase
extraction and for the liquid chromatography, than did
the use of trifluoroacetic acid. This was especially true
of succinylmonocholine and choline, which are the least
retained of all of these compounds on C18. The incor-
poration of heptafluorobutyric acid provided good re-
coveries of these compounds from the solid-phase ex-
traction, and highly reproducible chromatographic
retention times. This overall analytical strategy of using
a modified Bligh and Dyer extraction in reverse com-
pared with the original, followed by a reverse phase ion
pairing extraction, provides excellent recoveries of
these challenging compounds from most tissue speci-
mens (based upon recoveries from spiked tissue
homogenates).
Product ion spectra of succinylcholine, succinyl-
monocholine, and the internal standard [2H4]succinyl-
monocholine are shown in Figure 1, with the fragmen-
tation pattern of succinylmonocholine depicted inFigure 2. The abundances of the m/z 99 and 101 ions
relative to each other were quite reproducible, but the
abundance of these two relative to the more intense m/z
145 ion occasionally exhibited some variability, such
that the abundance of the m/z 99 ion relative to the m/z
145 ion could be as little as 10% or as high as 70% under
nominally identical conditions. This probably reflects
variations in the internal energy content due to minor
fluctuations in ion source conditions or subtle matrix
effects upon the desolvation process. With the low
collision energy involved (23 eV in the laboratory frame
of reference), small changes in internal energy content
can have a substantial effect on fragmentation path-
ways and, thus, product ion intensity ratios. Fortu-
nately, on the occasions when this was observed, this
posed no problem with identifying succinylmonocho-
line because alterations in internal energy content were
similarly reflected in the averaged product ion spec-
trum of the [2H4]succinylmonocholine obtained during
the same analysis, as would be expected for isotopically
labeled material. Variations in product ion intensity
ratios were less of an issue with the larger compounds.
Product ion spectra of pancuronium, vecuronium,
tubocurarine, and rocuronium are shown in Figure 3.
These are some of the most commonly encountered of
the larger (and longer acting) quaternary neuromuscu-
lar blocking drugs. Because of the large number of
compounds involved in these studies, complete spectra
are not shown for all of the compounds. Rather, the
product ion spectral data are summarized in Table 3
along with other analytical parameters pertinent to each
analyte.
Not all of these compounds are monitored during
typical analyses of biological specimens in this labora-
tory. Several of these compounds elute at very similar
retention times, and monitoring for all of them would
compromise overall sensitivity due to the necessity of
overlapping product ion scanning functions. Some of
the parent compounds are seldom detected in intact
form. Succinylcholine, atracurium, mivacurium, and
doxacurium are all symmetric bis-esters, each contain-
ing two quaternary ammonium functions, one at either
end of the molecule. Not only are these compounds
potentially subject to the actions of endogenous esterase
enzymes, but they are also inherently chemically unsta-
ble, readily undergoing hydrolysis (especially under
basic conditions) to yield quaternary alcoholic and
quaternary acidic breakdown products. Atracurium
also undergoes chemical degradation to yield the alka-
loid laudanosine and a quaternary monoacrylate as
breakdown products [15, 16]. The instability of these
four drugs is such that the parent compounds often do
not survive the analytical process, even with spiked
specimens; this is especially true for atracurium and
mivacurium. Based upon the experience of this labora-
tory, laudanosine and atracurium quaternary acid are
the breakdown products most useful for initial testing
to indicate atracurium exposure. Similarly, mivacurium
quaternary alcohol and doxacurium quaternary alcohol
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and doxacurium, respectively, (see Table 2). Since suc-
cinylcholine and doxacurium elute in completely sepa-
rate retention windows, they are routinely monitored
despite the fact that they are seldom detected intact in
biological specimens. Figure 4 depicts high-resolution
mass chromatograms (one ion per analyte) from a
spiked brain specimen (spiked at 80 ng/g) showing the
13 analytes (representing nine drugs plus the internal
standard) routinely monitored in this laboratory during
initial tests of biological specimens. If one or more of
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Figure 1. Product ion spectra of succinylcholi
[2H4]succinylmonocholine.
Figure 2. The fragmentation pattern of succinylmonocholine
under low-energy CAD conditions. The asterisks indicate the
positions of the labels in the deuterated material.these breakdown products of an unstable drug is de-
tected, the specimens can be reinjected with appropriate
scanning functions added (and extraneous functions
removed) to monitor for other drug breakdown prod-
ucts and for the parent drug itself. (It should be noted
that the weak signal corresponding to succinylcholine
in Figure 4 is due to the trace amount of residual
succinylcholine in the succinylmonocholine prepara-
tion. Succinylcholine itself is not routinely included in
the spiked samples for reasons cited above.)
The brain specimen involved in Figure 4 was positive
for vecuronium and succinylmonocholine. The samples
from that analysis were reinjected with most of the extra-
neous scanning functions removed to permit focusing the
analysis upon vecuronium (and succinylmonocholine,
data not shown). High-resolution mass chromatograms
representing significant ions for vecuronium from the
native (unspiked) specimen are shown in Figure 5a, with
corresponding traces for the specimen spiked at the 80
ng/g level shown in Figure 5b. For the native specimen,
each trace exhibits a single chromatographic peak at the
same retention time, with intensity ratios and retention
time appropriate for vecuronium (the upper right hand
corner of each trace shows them/z range for that trace and,
immediately below, the peak intensity for that trace). The
spiked specimen shows a single chromatographic peak for
160 170 180 190 200 210 220 230 240
m/z
1
171.0 230.1
uccinylmonocholine, and the internal standard150
0
46.0
149.1
150.
1
45.6
ne, seach trace with no evidence of chromatographic inhomo-
um, v
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by a factor of 4.5 compared to the native specimen (in
terms of absolute signal intensity). Product ion spectra,
combined across the chromatographic peak of interest, for
the native and spiked specimens are shown in Figure 6a.
The spectra have an obvious similarity, with all of the
ions characteristic of vecuronium (see Figure 3b)
present and in the appropriate ratios, with the absolute
signal intensity suitably increased with the spiked spec-
imen as compared to the native specimen. Figure 6b
shows expanded portions of these spectra with the
vertical axes linked, demonstrating the isobaric nature
of the signal increase with the spiked specimen for the
m/z 356 ion. This isobaric signal increase occurred with
all of the ions characteristic of vecuronium. Additional
and apparently spurious ions in the spectra, such as the
m/z 129 ion, were demonstrably chromatographically
distinct from the vecuronium ions, i.e., were due to a
neighboring and overlapping chromatographic peak.
Based on this analysis, using the method of standard
additions for chromatographic peak areas and taking
into account the response of the internal standard, this
specimen, as it was received, contained vecuronium at a
level of 28 ng/g of brain (without the internal stan-
dard taken into account, the calculated result was 25
ng/g).
The foregoing typical example demonstrates that the
criteria for defining a positive finding are based upon
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Figure 3. Product ion spectra of pancuronicomparing the analyses of native (unspiked) and spikedsamples. The spiked specimens, as matrix-matched pos-
itive controls, serve very important functions for both
quantitative and especially qualitative purposes. Some
of the criteria are applicable to the comparative product
ion spectra, combined across the region of elution of a
given analyte. Since these are full-scan data, all of the
significant ions characteristic of the analyte must be
observed with the native specimen. In comparing the
combined spectra from the native and spiked samples,
the absolute intensities of each of the characteristic
product ions must increase with the spiked sample, and
this increase must be isobaric at high resolution, with no
mass spectrometric peak splitting, or the appearance of
new ions in the high-resolution spectrum from the
spiked specimen. The relative abundances of the ob-
served product ions must be comparable between the
two analyses. Correspondingly, high-resolution mass
chromatograms of the various product ions must ex-
hibit appropriate characteristics. Native specimens
must exhibit chromatographically homogeneous co-
maximization of all significant ions at high resolution,
at the appropriate ratios, with spiked specimens show-
ing the same chromatographic homogeneity at appro-
priately increased intensity. All of these criteria must be
met in order for a specimen to be considered positive
for a given analyte. In the case of succinylmonocholine,
it must also be observed that the analyte elutes from the
chromatographic system just slightly later than the
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472431
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3[2H4]succinylmonocholine internal standard (typically
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scribed above).
Several of these compounds are potentially suscep-
tible to esterase activity. The inclusion of paraoxon in all
samples as an esterase inhibitor improved recoveries of
the intact drugs, particularly with blood and plasma
specimens, but also for the tissue specimens, most
notably liver, that also exhibit esterase activity.
Table 4 presents a comparison of the quantitative
results for succinylmonocholine in four forensic speci-
mens using the method of standard additions versus a
serum standard curve incorporating the deuterated
internal standard. (These standard addition data were
calculated using a straightforward standard addition
calculation based upon peak areas without taking into
account the response of the internal standard.) The
decedent in Case 1 had been embalmed, then autopsied
before burial, with the specimens stored frozen for
several years. The decedent in Case 2 had been em-
balmed, buried several years, then exhumed and autop-
sied, with the specimens frozen for years. Of all the
analytes in these studies, the only ones for which an
isotopically labeled internal standard is available are
succinylcholine, succinylmonocholine, and choline. Ob-
viously, the best quantitative data are obtained when an
isotopically labeled internal standard is used. For the
  Spiked Brain Specimen 
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Figure 4. High-resolution mass chromatogram
showing the 13 analytes (representing nine dru
during initial tests of biological specimens.other analytes, the method of standard additions is themost appropriate means of quantitative estimation be-
cause the quantitative data are necessarily matrix
matched, and each specimen serves as its own control.
The data in Table 4 demonstrate the validity of this
approach because the numbers are essentially the same
using the two approaches with an analyte for which a
deuterated internal standard is available. The spiked
specimens also serve additional quality control func-
tions. They permit estimating recovery efficiency and
detection limits for each specimen, and can identify an
analytical failure. A few specimens have been identified
over the years from which the quaternary ammonium
analytes could not be recovered at any meaningful
detection limit, and these specimens were identified by
the fact that there was no recovery even with high
spiking levels, and despite the fact that the rest of the
run (serum standards, other spiked specimens, etc.)
exhibited good recoveries. All analytes exhibited good
stability under frozen conditions, but some analytes
deteriorated with time under refrigerated or room-
temperature storage conditions.
During the course of these studies, it was discovered
that succinylmonocholine is present at relatively low
levels in normal fresh posthumous liver and kidney,
typically at a level of less than 50 ng/g for each of these
tissues, from human and nonhuman sources. This has
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gs pnot yet been thoroughly investigated. Succinylmono-
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and thus far it has not been observed in normal brain. It
is not known now whether succinylmonocholine is
present in living tissue, or whether this represents a
postmortem phenomenon (both succinic acid and cho-
line are present at g/ml levels in human blood [30],
and their concentrations may be high in the tissues as
well). If succinylmonocholine is present in living tis-
sues, the obvious pharmacologic implication is that
succinylcholine and/or succinylmonocholine may be
involved in cholinergic neurotransmission.
Another interesting observation from these studies is
that several cases have been encountered involving
both high concentrations of pancuronium and low
concentrations of vecuronium. Some such cases in-
volved documented exposure to pancuronium but no
documented exposure to vecuronium. Structurally, ve-
curonium is N-demethylated pancuronium (see Table
1). It seems likely that the low levels of vecuronium
observed in these cases were actually derived from the
pancuronium, through either chemical or metabolic
processes. The incorporation of analyzing for the des-
acetylated metabolites of pancuronium, vecuronium,
and rocuronium into this analytical panel is a relatively
recent development. One recent blood specimen involv-
ing high pancuronium levels also exhibited des-acetyl
pancuronium, des-diacetyl pancuronium, vecuronium,
 (a)
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Figure 5. (a) High-resolution mass chromatog
from the native (unspiked) brain specimen from
spiked at the 80 ng/g level.and des-acetyl vecuronium. Although the primary focus of the present paper is
the analytical strategy itself, a brief description of its
applicability is warranted. This overall analytical strat-
egy is highly efficient, with recoveries of these analytes
generally in the 80 to 95% range from human serum.
The overall method was applicable to a broad range of
sample types, exhibiting good recoveries and low de-
tection limits (typically 2–10 ng/g) for most samples
analyzed. These samples included biological fluids such
as blood, serum, plasma, urine, vitreous fluid, and bile.
The great majority of samples, however, were various
types of tissues in various states of preservation as
described above. As a general rule, good results were
obtained with kidney, brain, diaphragm, spleen, lung,
blood, serum, plasma, and urine. Poorer recoveries
were generally observed with skeletal and heart muscle.
Liver and bile generally gave good results, but occa-
sional specimens gave poor recoveries. As a general
rule, the best specimens for initial analysis for the
neuromuscular blocking agents are kidney, brain, liver,
and diaphragm. On the rare occasions when intact
succinylcholine was identified, it was generally in urine
or kidney. The question is occasionally asked as to why
brain is a good specimen for these analyses, since
quaternary compounds would not be expected to cross
the blood-brain barrier. The most likely answer is
because of the brain’s tremendous blood supply; the
 (b)
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 Figubrain is full of blood. At the microscopic level, at the
this s
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the blood within the arteries, veins, and capillaries
within the brain matrix, but at the macroscopic level
after autopsy, the brain is a good specimen for these
analyses. Since most of these analytes are more stable
under mildly acidic conditions than under neutral or
basic conditions, possibly the embalming process,
which typically involves mildly acidic solutions, actu-
ally helps preserve these compounds in tissues.
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Figure 6. (a) Product ion spectra, combined a
native and spiked brain specimens from Figure 
6a with the vertical axes linked to the same abs
signal increase with the spiked specimen for the
with all of the ions relevant to vecuronium for
Table 4. Comparison of the results of quantitative estimation
using a standard curve based upon the
[2H4]succinylmonocholine internal standard versus the method
of standard additions (without taking into account the internal
standard)*
Sample
Succinylmonocholine
quantification with
internal
standardization
(ave. of 4–8),
ng/g of tissue
Succinylmonocholine
Quantification
by Standard
Additions
(ave. of 2–4),
ng/g of tissue
Case 1 kidney 227 214
Case 1 spleen 21 20
Case 1 brain 42.5 52.6
Case 2 kidney 50.3 48.8*Data for the two approaches were acquired on the same specimens
within the same run. The two approaches give similar values.The analytes most commonly encountered in submit-
ted specimens have been pancuronium, vecuronium,
and rocuronium. More seldom, atracurium and miva-
curium have been encountered. With the latter two, the
breakdown products of these drugs (vide supra) have
been especially important. For atracurium, in most
instances all four of its breakdown products were
found, but little or no intact parent drug. In a few
atracurium cases, the only breakdown products ob-
served were the two smallest ones, atracurium quater-
nary acid and the alkaloid laudanosine. Similarly, for
mivacurium, both of its breakdown products were
generally observed, with little or no intact mivacurium
found. An occasional specimen has been positive for
tubocurarine.
Quite a number of interesting cases have been en-
countered during the course of these studies. There are
at least two ongoing serial homicide investigations
involving medical professionals as suspects, where suc-
cinylcholine may have been used as a murder weapon.
In two separate cases involving anesthesiologists com-
mitting suicide, both cases involved high blood levels of
pancuronium, in addition to high levels of sedative-
hypnotic drugs and opioids. Another interesting case
involved what was ostensibly a death due to a fire. The
 b)
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) Expanded portions of the spectra from Figure
 scale, demonstrating the isobaric nature of the
56 ion. Similar isobaric increases were observed
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olute
m/z 3pathologist in the case noted that the victim’s blood
.1467J Am Soc Mass Spectrom 2006, 17, 1456–1468 ANALYTICAL STRATEGY FOR QUATERNARY DRUGScarbon monoxide level was not elevated, which indi-
cated that the victim was already dead when the fire
occurred. The victim’s spouse was a medical profes-
sional. Specimens of heart blood and liver tissue from
the decedent were submitted to this laboratory for
analysis for a wide variety of drugs, including the
neuromuscular blocking agents. Significant findings
from these specimens are depicted in Figure 7, which
shows product ion spectra obtained from standard
rocuronium and from the two case specimens. All of the
chromatographic and mass spectrometric criteria de-
scribed above were met, and rocuronium was unequiv-
ocally identified in both specimens from the decedent.
The rocuronium concentration in the blood was 4.9
g/mL, and the liver rocuronium concentration was
14.4 g/g. In another case involving a suspected homi-
cide or suicide, the pathologist wondered whether a
poisoning agent had been injected at the injection site
where an insulin pump had been in place on the
decedent (as was normal for this decedent), in an
attempt to cover up the homicide or suicide. The
excised injection site was divided into three layers,
namely skin, fat, and underlying muscle. All three
layers were positive for all four atracurium breakdown
products.
This overall approach has also been useful for clini-
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Figure 7. Product ion spectra, combined acros
blood from a suspected murder victim, (b) l
rocuronium extracted from spiked human serumcal work. Two recent clinical cases from separate partsof the country involved prolonged paralysis in pediatric
patients following routine administration of vecuro-
nium during surgical procedures. In both cases, the
patients were paralyzed for more than three weeks after
the last administration of the paralytic drug, and both
patients had to be maintained on a respirator for that
extended period of time. In both instances, the pro-
longed paralysis was explained by the persistence in the
patients’ bodies of both the parent drug and its active
metabolite, des-acetyl vecuronium, which has about 50
to 70% of the parent drug’s activity [31]. It is unknown
why these two patients were unable to eliminate the
drug and metabolite in a normal efficient fashion.
Conclusions
The overall analytical strategy described here reliably
extracts quaternary ammonium neuromuscular block-
ing agents and their breakdown products from a wide
variety of forensic sample matrices. Likely, this strategy
will be applicable to other types of analytes with similar
problematic characteristics, and to other types of sam-
ples, such as plant materials. With most specimens,
detection limits were generally in the 2 to 10 ng/g
range. While it might be possible to push the detection
limits even lower, it is doubtful that findings below this
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ectra
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iverlevel would be meaningful, particularly in court. The
1468 BALLARD ET AL. J Am Soc Mass Spectrom 2006, 17, 1456–1468use of matrix matched spiked samples for both qualita-
tive and quantitative control purposes is essential with
the unique specimens encountered in a forensic setting.
The Q-TOF is an excellent platform for forensic
analytical investigations, and is clearly superior to a
tandem quadrupole for forensic LC-MS/MS. By provid-
ing full scan product ion spectra at high resolution and
at high sensitivity, the Q-TOF provides a tremendous
amount of analytical confidence for forensic work,
where the qualitative findings are often the most im-
portant.
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